中文产业新闻评分54Chinese source
罗氏Tecentriq获FDA批准用于III期dMMR结肠癌术后辅助治疗
罗氏结肠癌免疫辅助疗法获FDA批准；特发性肺纤维化新机制疗法2b期结果积极……｜产业新闻
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
罗氏结肠癌免疫辅助疗法获FDA批准；特发性肺纤维化新机制疗法2b期结果积极……｜产业新闻
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.